Información del producto
Btk inhibitor 2 is a protein kinase inhibitor that was developed to target the B-cell lymphoma tumor necrosis factor receptor. It binds to the ATP binding site of Btk and prevents activation of the kinase. This drug has been shown to be effective in treating cancer by inhibiting cancer-related genes and promoting apoptosis in cancer cells. The drug has also been shown to have an effect on skeletal muscle, with a dose-dependent response for increasing muscle mass and decreasing fat content.
Propiedades químicas
Consulta técnica sobre: 3D-IMC03685 Btk inhibitor 2
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.